Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Margins of Excision × Chemoradiotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 34 Esophageal Neoplasms 17 Carcinoma, Non-Small-Cell Lung 16 Squamous Cell Carcinoma of Head and Neck 15 Nasopharyngeal Carcinoma 10 Pancreatic Neoplasms 9 Head and Neck Neoplasms 9 Uterine Cervical Neoplasms 8 Oropharyngeal Neoplasms 8 Esophageal Squamous Cell Carcinoma 6 Neoplasms 5 Lung Neoplasms 5 Carcinoma, Squamous Cell 5 Urinary Bladder Neoplasms 4 Stomach Neoplasms 4 Mouth Neoplasms 4 Glioblastoma 4 Colorectal Neoplasms 4 Carcinoma 4 Adenocarcinoma 4 Pathologic Complete Response 3 Laryngeal Neoplasms 3 Hypopharyngeal Neoplasms 3 Breast Neoplasms 3 Thymoma 2 Resectable Esophageal Cancer 2 Radiation Injuries 2 Neoplasms by Site 2 Nasopharyngeal Neoplasms 2 NSCLC 2

Interventions

Indocyanine Green 2 Dermoscopy 2 varlilumab 1 Ultrasonography 1 Tumor Burden 1 Simvastatin 1 Radiosurgery 1 Observation 1 Neoadjuvant Therapy 1 Narrow Band Imaging 1 Microscopy, Confocal 1 Mastectomy, Segmental 1 Interferon alpha-2 1 IFL protocol 1 Gastrectomy 1 Folfox protocol 1 Everolimus 1 Endoscopic Mucosal Resection 1 Drug Delivery Systems 1 Drug Combinations 1 Chemoradiotherapy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04389086 2022-09-06

PelvEx II

Catharina Ziekenhuis Eindhoven

Phase 3 Recruiting

Gastrointestinal

Margins of Excision, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡